Results 151 to 160 of about 184,107 (180)

Aging-associated alterations in gene regulatory networks associate with risk, prognosis and response to therapy in lung adenocarcinoma. [PDF]

NPJ Aging
Saha E, Ben Guebila M, Fanfani V, Shutta KH, DeMeo DL, Quackenbush J, Lopes-Ramos CM.   +6 more
europepmc   +1 more source

Aflatoxin exposure, chronic hepatitis infection, and HLA diversity converge to shape patient survival in hepatocellular carcinoma. [PDF]

Cancer Epidemiol Biomarkers Prev
Guo Y, Jiang L, Alkali M, George SH, Jones PD, Leng S, Ye F.   +6 more
europepmc   +1 more source

Computational methods and data resources for predicting tumor neoantigens. [PDF]

Brief Bioinform
Zhao X, Wei L, Zhang X.
europepmc   +1 more source

Computational investigation of missense somatic mutations in cancer and potential links to pH-dependence and proteostasis. [PDF]

PLoS One
Sallah S, Warwicker J.
europepmc   +1 more source

In silico protein structural analysis of PRMT5 and RUVBL1 mutations arising in human cancers. [PDF]

Cancer Genet
Al-Marrawi M, Petreaca RC, Bouley RA.
europepmc   +1 more source

CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis. [PDF]

Front Immunol
Liu C, Liu Q, Lv Y, Chang T, Song S, Ding Y, Zhong J, Liu Y.   +7 more
europepmc   +1 more source

Beyond Tumors: Reduced Survival Linked to Pathogenic PIK3CA and TP53 Post-Zygotic Variants in the Uninvolved Breast Tissue of Recurrent Cancer Patients

Andreou M, Chojnowska K, Filipowicz N, Horbacz M, Madanecki P, Duzowska K, Ławrynowicz U, Davies H, Bruhn-Olszewska B, Koszyński M, Drężek-Chyła K, Jaśkiewicz M, Jąkalski M, Kostecka A, Drzewiecka-Kłysz M, Nowikiewicz M, Las-Jankowska M, Bała D, Hoffman J, Śrutek E, Jankowski M, Jankau J, Hodorowicz-Zaniewska D, Szpor J, Szylberg Ł, Zegarski W, Nowikiewicz T, Buckley PG, Tiemann-Boege I, Mieczkowski J, Koczkowska M, Dumanski JP, Piotrowski A.   +32 more
europepmc   +1 more source